Alerts will be sent to your verified email
Verify Email
VINEETLAB
|
Vineet Laboratories
|
Amwill Health Care
|
Asston Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
6.82 % | 84.18 % | 31.69 % |
|
5yr average Equity Multiplier
|
4.27 | 0.32 | 5.73 |
|
5yr Average Asset Turnover Ratio
|
1.52 | 2.35 | 0.79 |
|
5yr Avg Net Profit Margin
|
-4.28 % | 13.8 % | 10.83 % |
|
Price to Book
|
4.99 | 0.0 | 0.0 |
|
P/E
|
0.0 | 6.47 | 15.55 |
|
5yr Avg Cash Conversion Cycle
|
179.8 Days | 115.9 Days | 121.8 Days |
|
Inventory Days
|
114.74 Days | 26.46 Days | 31.3 Days |
|
Days Receivable
|
109.14 Days | 133.46 Days | 296.65 Days |
|
Days Payable
|
115.29 Days | 129.03 Days | 343.23 Days |
|
5yr Average Interest Coverage Ratio
|
1.29 | 0.0 | 3.57 |
|
5yr Avg ROCE
|
-1.66 % | 102.76 % | 42.37 % |
|
5yr Avg Operating Profit Margin
|
-0.62 % | 17.69 % | 15.11 % |
|
5 yr average Debt to Equity
|
1.24 | 0.0 | 1.99 |
|
5yr CAGR Net Profit
|
n/a | 33.09 % | 108.46 % |
|
5yr Average Return on Assets
|
-2.52 % | 26.84 % | 7.75 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
5.98 % | 70.65 % | 50.66 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-32.68 % | 0.0 | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Vineet Laboratories
|
Amwill Health Care
|
Asston Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|